Additionally, high expression of EPHB2 receptors and their ligands, ephrinB1 and ephrinB2, is associated with metastasis in CCA and targeting EPHB2 expression and its downstream signaling proteins may hold therapeutic potential [118]. This evidence concerns the gene EPHB2 and cholangiocarcinoma.